| Ident. | Authors (with country if any) | Title |
|---|
| 000139 (2020) |
Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France] | Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study |
| 000169 (2020) |
Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie] | Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. |
| 000219 (2020) |
Ayako Matsumura [Japon] ; Takuya Miyazaki [Japon] ; Takayoshi Tachibana [Japon] ; Taiki Ando [Japon] ; Megumi Koyama [Japon] ; Satoshi Koyama [Japon] ; Yoshimi Ishii [Japon] ; Hiroyuki Takahashi [Japon] ; Yuki Nakajima [Japon] ; Ayumi Numata [Japon] ; Wataru Yamamoto [Japon] ; Kenji Motohashi [Japon] ; Maki Hagihara [Japon] ; Kenji Matsumoto [Japon] ; Shin Fujisawa [Japon] ; Hideaki Nakajima [Japon] | Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study |
| 000571 (2020) |
Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon Choe | Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry. |
| 000704 (2019) |
Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon] | Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study. |
| 000705 (2019) |
Shuntaro Saito ; Ayumi Okuyama ; Yusuke Okada ; Akiko Shibata ; Ryota Sakai ; Takahiko Kurasawa ; Tsuneo Kondo ; Hirofumi Takei ; Koichi Amano | Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study. |
| 000841 (2019) |
S Ren Andreas Just [Danemark] ; Christian Nielsen [Danemark] ; Jens Christian Werlinrud [Danemark] ; Pia Veldt Larsen [Danemark] ; Camilla Schufri Klinkby [Danemark] ; Henrik Daa Schr Der [Danemark] ; Fran Humby [Royaume-Uni] ; Trine Torfing [Danemark] ; Hanne Lindegaard [Danemark] | Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score |
| 000879 (2019) |
Wataru Fukuda ; Tadamasa Hanyu ; Masaki Katayama ; Shinichi Mizuki ; Akitomo Okada ; Masayuki Miyata ; Yuichi Handa ; Masatoshi Hayashi ; Yoshinobu Koyama ; Kaoru Arii ; Toshiyuki Kitaori ; Hiroyuki Hagiyama ; Yoshinori Urushidani ; Takahito Yamasaki ; Yoshihiko Ikeno ; Takeshi Suzuki ; Atsushi Omoto ; Toshifumi Sugitani ; Satoshi Morita ; Shigeko Inokuma | Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital |
| 000913 (2019) |
Carlotta Nannini [Italie] ; Laura Niccoli [Italie] ; Stelvio Sestini [Italie] ; Iashar Laghai [Italie] ; Angela Coppola [Italie] ; Fabrizio Cantini [Oman] | Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study. |
| 000915 (2019) |
Olivier Vittecoq [France] ; Sandra Desouches [France] ; Marie Kozyreff [France] ; Julia Nicolau [France] ; Sophie Pouplin [France] ; Pascal Rottenberg [France] ; Nicolas Sens [France] ; Thierry Lequerre [France] ; Gilles Avenel [France] | Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study |
| 000968 (2019) |
Kenneth F. Baker [Royaume-Uni] ; Andrew J. Skelton [Royaume-Uni] ; Dennis W. Lendrem [Royaume-Uni] ; Adam Scadeng [Royaume-Uni] ; Ben Thompson [Royaume-Uni] ; Arthur G. Pratt [Royaume-Uni] ; John D. Isaacs [Royaume-Uni] | Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study |
| 000B87 (2019) |
Yann Nguyen [France] ; Carine Salliot [France] ; Gaëlle Gusto [France] ; Elise Descamps [France] ; Xavier Mariette [France] ; Marie-Christine Boutron-Ruault [France] ; Raphaèle Seror [France] | Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study |
| 000E47 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
| 001141 (2018) |
Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon] | Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). |
| 001144 (2018) |
Maxime Samson [France] ; Hervé Devilliers [France] ; Kim Heang Ly [France] ; François Maurier [France] ; Boris Bienvenu [France] ; Benjamin Terrier [France] ; Pierre Charles [France] ; Loïc Guillevin [France] ; Jean-François Besancenot [France] ; Eric Liozon [France] ; Anne Laure Fauchais [France] ; Romaric Loffroy [France] ; Christine Binquet [France] ; Sylvain Audia [France] ; Raphaèle Seror [France] ; Xavier Mariette [France] ; Bernard Bonnotte [France] | Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. |
| 001205 (2018) |
Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France] | Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data. |
| 001394 (2018) |
Jun Kikuchi [Japon] ; Tsuneo Kondo [Japon] ; Akiko Shibata [Japon] ; Ryota Sakai [Japon] ; Yusuke Okada [Japon] ; Kentaro Chino [Japon] ; Ayumi Okuyama [Japon] ; Takahiko Kurasawa [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon] | Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis. |
| 001674 (2017) |
Le-Feng Chen [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jian-Da Ma [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Lie Dai [République populaire de Chine] | Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation. |
| 001676 (2017) |
E L Kneepkens [Pays-Bas] ; Iam Van Den Oever [Pays-Bas] ; C H Plasencia [Espagne] ; D. Pascual-Salcedo [Espagne] ; A. De Vries [Pays-Bas] ; M. Hart [Pays-Bas] ; M T Nurmohamed [Pays-Bas] ; A. Balsa [Espagne] ; T. Rispens [Pays-Bas] ; G. Wolbink [Pays-Bas] | Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study. |
| 001742 (2017) |
Zoila Lopez-Bujanda ; Charles G. Drake | Myeloid‐derived cells in prostate cancer progression: phenotype and prospective therapies |
| 001779 (2017) |
Bruno Cesar Bacchiega [Oman] ; Ana Beatriz Bacchiega [Brésil] ; Magali Justina Gomez Usnayo [Brésil] ; Ricardo Bedirian [Brésil] ; Gurkirpal Singh [États-Unis] ; Geraldo Da Rocha Castelar Pinheiro [Brésil] | Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study. |
